HNF1A型
青少年成熟型糖尿病
先证者
葡萄糖激酶
医学
内科学
遗传学
糖尿病
突变
内分泌学
基因
2型糖尿病
生物
作者
James L. McKinney,Henian Cao,John F. Robinson,Daniel L. Metzger,Elizabeth A. Cummings,D. Christie Riddell,Susan Sanderson,Danièle Pacaud,Josephine Ho,Robert A. Hegele
出处
期刊:PubMed
日期:2004-06-01
卷期号:27 (3): 135-41
被引量:30
摘要
Maturity-onset diabetes of the young (MODY) is a subtype of type 2 diabetes characterized by autosomal-dominant inheritance and early onset. The pathophysiology of MODY is primarily defective insulin secretion resulting from mutations in at least 6 different genes. Most affected patients harbour mutations in either GCK (encoding glucokinase, also called MODY2) and HNF1A (encoding hepatic nuclear factor-1alpha, also called MODY3). We studied Canadian probands to determine if they had mutations in MODY2 or MODY3 genes.We used genomic DNA sequencing of probands from 9 previously unreported Canadian MODY families.Five MODY probands had mutations in HNF1A, of which 4 were novel (namely IVS5-1delTAG, E275fsdelGAAG, F268S and L44fsdelC) and 4 had mutations in GCK, of which 2 were novel (E237K and L324P). These mutations expand the spectrum of MODY mutations and bring the total number of Canadian MODY families that have been molecularly defined in our laboratory to 15 (8 MODY3 and 7 MODY2).Because of the growing evidence that molecular diagnosis may affect prognosis and treatment, this information may be important in future for Canadian MODY families and their physicians.
科研通智能强力驱动
Strongly Powered by AbleSci AI